AbstractWe demonstrate the potential of cloning by homologous recombination as a rapid method to construct DNA molecules encoding newly developing hemagglutinins (HA) of influenza A virus. The variable parts of the HA genes were cloned into a basic construct containing the HA gene from an H3N2 strain. The recombinant DNAs thus created encode different variable domains with neutralising epitopes from four recently circulating influenza A H3 strains. The technology allows rapid production of DNA constructs for vaccines that can induce antibody and, particularly, cellular immune responses. These new constructs were also capable of conferring protection to challenge in mice. The technology may hence be a valuable tool for rapid adaptation of in...
Approaches to improve the efficacy of the current (killed) influenza virus vaccines include the gene...
<div><p>Influenza A viruses (IAVs) are the most relevant and continual source of severe infectious r...
There is a need to develop a universal vaccine against influenza virus infection to avoid developing...
AbstractWe demonstrate the potential of cloning by homologous recombination as a rapid method to con...
BACKGROUND: Vaccination is considered the most effective means of reducing influenza burden. The eme...
Background: Development of a universal vaccine capable to induce antibody responses against a broad ...
<div><p>Background and Objectives</p><p>Influenza A viruses cause highly contagious diseases in a va...
DoctorAmong emerging and re-emerging infectious diseases, influenza constitutes one of the major thr...
Zoonotic influenza H7 viral infections have a case fatality rate of about 40%. Currently, no or limi...
Influenza A viruses (IAVs) are the most relevant and continual source of severe infectious respirato...
Genetic vaccine technology has been considerably developed within the last two decades. This cost ef...
AbstractThe global system for manufacturing seasonal influenza vaccines has been developed to respon...
Background and Objectives Influenza A viruses cause highly contagious diseases in a variety of hosts...
DNA-based immunizations have been used to analyze the ability of DNA-expressed hemagglutinin (HA) an...
Influenza vaccination practice, which is based on neutralizing antibodies, requires being able to pr...
Approaches to improve the efficacy of the current (killed) influenza virus vaccines include the gene...
<div><p>Influenza A viruses (IAVs) are the most relevant and continual source of severe infectious r...
There is a need to develop a universal vaccine against influenza virus infection to avoid developing...
AbstractWe demonstrate the potential of cloning by homologous recombination as a rapid method to con...
BACKGROUND: Vaccination is considered the most effective means of reducing influenza burden. The eme...
Background: Development of a universal vaccine capable to induce antibody responses against a broad ...
<div><p>Background and Objectives</p><p>Influenza A viruses cause highly contagious diseases in a va...
DoctorAmong emerging and re-emerging infectious diseases, influenza constitutes one of the major thr...
Zoonotic influenza H7 viral infections have a case fatality rate of about 40%. Currently, no or limi...
Influenza A viruses (IAVs) are the most relevant and continual source of severe infectious respirato...
Genetic vaccine technology has been considerably developed within the last two decades. This cost ef...
AbstractThe global system for manufacturing seasonal influenza vaccines has been developed to respon...
Background and Objectives Influenza A viruses cause highly contagious diseases in a variety of hosts...
DNA-based immunizations have been used to analyze the ability of DNA-expressed hemagglutinin (HA) an...
Influenza vaccination practice, which is based on neutralizing antibodies, requires being able to pr...
Approaches to improve the efficacy of the current (killed) influenza virus vaccines include the gene...
<div><p>Influenza A viruses (IAVs) are the most relevant and continual source of severe infectious r...
There is a need to develop a universal vaccine against influenza virus infection to avoid developing...